Xipere
NDC Package 71565-040-01

View Billable Units, 11-Digit Conversion Format, and RxNorm mappings
Table of Contents
    1. Package Information
    2. Other Packages
    3. Frequently Asked Questions

Package Information

This product is EXCLUDED from the official NDC directory because the listing data was discontinued by the firm.

Xipere is a . Marketed by Clearside Biomedical, Inc., this product is identified by NDC 71565-040 and is authorized under FDA application NDA211950.

Identification & Billing

NDC Package Code
71565-040-01
Package Description
1 TRAY in 1 CARTON / 1 VIAL in 1 TRAY / .9 mL in 1 VIAL (71565-040-25)
Product Code
71565-040
11-Digit Billing Format
71565004001
Billing Unit
ML - Billing unit of "milliliter" is used when a product is measured by its liquid volume.

Clinical Specifications

Proprietary Name
Xipere
Dosage Form
-

Regulatory & Marketing

Labeler Name
Clearside Biomedical, Inc.
FDA Application #
NDA211950
Marketing Category
NDA - A product marketed under an approved New Drug Application.
Start Marketing Date
11-12-2021
End Marketing Date
07-31-2024
Listing Expiration
07-31-2024
Exclude Flag
D
Sample Package
No

Hierarchy Structure

Code Lineage

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the full disclaimer at the bottom of this page.

Other Available Packages

The following commercial packages are registered under the same Product NDC (71565-040). Click a package code to view its specific billing and regulatory data.

71565-040-99
1 TRAY in 1 CARTON / 1 VIAL in 1 TRAY / .9 mL in 1 VIAL (71565-040-95)

* Please review the full disclaimer at the bottom of this page.

Frequently Asked Questions

What is the distribution configuration for this product package?

The code 71565-040-01 identifies a specific commercial package of 1 tray in 1 carton / 1 vial in 1 tray / .9 ml in 1 vial (71565-040-25) of Xipere, labeled by Clearside Biomedical, Inc.. This is formulated for use and contains as the active substance.

Is this product currently listed with the FDA?

This product code is currently listed as inactive or excluded from the primary directory. It was introduced to the market by Clearside Biomedical, Inc. on November 12, 2021. The current certification is valid through July 31, 2024.

How is this Clearside Biomedical, Inc. product billed for insurance claims?

For medical billing and reimbursement, this package follows the 11-digit CMS format: 71565004001. Quantities are measured in per "ml or milliliter", products billed per milliliter are usually products measured by liquid volume.. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.

11-Digit Code Conversion

Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:

10-Digit Format (5-3-2)
71565-040-01
11-Digit CMS (5-4-2)
71565-0040-01

Note: The zero is added to the Product segment to maintain the 5-4-2 structure.